Biodexa Pharmaceuticals PLC
Entity

  • Biodexa Pharmaceuticals PLC

    Created in 2000


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    4,417

  • Activities

    deeptech biotech

  • Entity types

    SMB

  • Location

    Emperor House, Pierhead St, Cardiff CF10 4PH, UK

    Cardiff

    United Kingdom

  • Employees

    Scale: 11-50

    Estimated: 22

  • Engaged catalyst

    0
    0 0

  • Added in Motherbase

    1 year, 10 months ago
Description
  • Value proposition

    [Automatic translation follows] Advancing Medicines for a Brighter Future

    Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain. The Company’s lead candidate, MTX110, is being studied in aggressive rare/orphan brain cancer indications including recurrent glioblastoma and diffuse midline glioma.

    MTX110 is a solubilised formulation of the histone deacetylase (HDAC) inhibitor, panobinostat. This proprietary formulation enables delivery of the product via convection-enhanced delivery (CED) at potentially chemotherapeutic doses directly to the site of the tumour, by-passing the blood-brain barrier and avoiding systemic toxicity.

  • Original language

    Advancing Medicines for a Brighter Future

    Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain. The Company’s lead candidate, MTX110, is being studied in aggressive rare/orphan brain cancer indications including recurrent glioblastoma and diffuse midline glioma.

    MTX110 is a solubilised formulation of the histone deacetylase (HDAC) inhibitor, panobinostat. This proprietary formulation enables delivery of the product via convection-enhanced delivery (CED) at potentially chemotherapeutic doses directly to the site of the tumour, by-passing the blood-brain barrier and avoiding systemic toxicity.

  • Advancing Medicines for a Brighter Future | Biodexa

    Biodexa Pharmaceuticals is a biopharmaceutical company developing a pipeline of products aimed at cancers of the brain.

    • https://biodexapharma.com/
Catalyst interactions
Catalyst TypeTweets Articles
No interactions
Social network dynamics
Last news
Show all articles